← Eichor
Condition: Healthy Volunteers Only Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Healthy Volunteers Only

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
Phase 1 · 14 location(s) · Sitryx Therapeutics Ltd · NCT07558668A Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses
Phase 1 · 1 location(s) · Beijing Suncadia Pharmaceuticals Co., Ltd · NCT07280936A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants
Phase 1 · 1 location(s) · Eisai Inc. · NCT07308236A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participan
Phase 1 · 1 location(s) · Hoffmann-La Roche · NCT07271693Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Ascending Doses BCD-261 in Healthy Subjects
Phase 1 · 1 location(s) · Biocad · NCT06715540A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adul
Phase 1 · 1 location(s) · AbbVie · NCT07604558A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function
Phase 1 · 1 location(s) · Shandong Suncadia Medicine Co., Ltd. · NCT07322016A Phase I Study to Evaluate LIFE-001
Phase 1 · 1 location(s) · LifeMine Therapeutics · NCT06904807A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4066708 in H
Phase 1 · 1 location(s) · Eli Lilly and Company · NCT07046559A Study of LY3867070 in Healthy Participants
Phase 1 · 2 location(s) · Eli Lilly and Company · NCT07021547Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants
Phase 3 · 1 location(s) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · NCT06344065Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function.
NA · 1 location(s) · Azienda Ospedaliero-Universitaria di Parma · NCT06888167A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers
Phase 1 · 1 location(s) · Bugworks Research Inc. · NCT07029932A Study to Learn About How Different Forms of Study Medicine Prifetrastat Are Taken Up Into the Blood in Healthy Adults
Phase 1 · 1 location(s) · Pfizer · NCT07721402A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2070 Inj
Phase 1 · 1 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07241923A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Ad
Phase 1 · 1 location(s) · Meiji Pharma USA Inc. · NCT07422207Investigating the Plasticity of Human Predictive Coding Through Neuromodulation
NA · 1 location(s) · Università Vita-Salute San Raffaele · NCT06374433Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject
Phase 1 · 1 location(s) · Beijing Tiantan Hospital · NCT06935721BnH-015B Clinical Trial in Moderate Alzheimer's Disease
Phase 1 · 1 location(s) · BnH Research · NCT06535308A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate
Phase 1 · 1 location(s) · Cinclus Pharma Holding AB · NCT05469854A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
Phase 1 · 2 location(s) · Novo Nordisk A/S · NCT06859073Effects of Hip Bump Manipulation Versus Sham Treatment in Healthy Adults
NA · 1 location(s) · Dominican University New York · NCT07025434Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessm
Phase 1 · 1 location(s) · Bristol-Myers Squibb · NCT07629999A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participan
Phase 1 · 1 location(s) · Zai Lab (Shanghai) Co., Ltd. · NCT07235384A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS
Phase 2 · 2 location(s) · Cerus Corporation · NCT07015437A Study to Evaluate ALN-4915 in Adult Healthy Volunteers
Phase 1 · 1 location(s) · Alnylam Pharmaceuticals · NCT07535606Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis
Phase 1 · 5 location(s) · Cystetic Medicines, Inc. · NCT05802264A First-in-human Trial of GRT7041 in Healthy Participants
Phase 1 · 1 location(s) · Grünenthal GmbH · NCT07289776A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body
Phase 1 · 1 location(s) · AbbVie · NCT07673120A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyal
Phase 1 · 3 location(s) · ViiV Healthcare · NCT05418868
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.